The FDA today told COVID-19 vaccine developers that it needs two months’ worth of safety data before it will consider emergency approvals.
The agency’s move cast further doubt on a vaccine against SARS-COV-2 being ready by election day, November 3 — a notion mentioned repeatedly by President Trump in attempts to pressure the agency to hasten its review process.
Get the full story on our sister site, Drug Discovery & Development.